文献速递肝病

二维剪切波弹性成像与衰减成像评估非酒精性脂肪性肝炎的准确性

Accuracy of Two-Dimensional Shear Wave Elastography and Attenuation Imaging for Evaluation of Patients With Nonalcoholic Steatohepatitis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2020-05-22

研究纳入102例肝酶升高或疑似NAFLD的患者,在肝活检前进行衰减成像和二维剪切波弹性成像检查。衰减系数可识别脂肪变分级(AUROC 0.93/0.88/0.83),肝硬度与纤维化分期相关,剪切波色散斜率与炎症分级相关(AUROC 0.89/0.85/0.78)。基于衰减系数和剪切波色散斜率构建的风险评分识别脂肪性肝炎的AUROC为0.93。

要点

  • 衰减系数可识别脂肪变分级S1以上、S2以上和S3以上,AUROC分别为0.93、0.88和0.83。
  • 剪切波色散斜率与小叶内炎症活动相关,识别炎症分级I1以上、I2以上和I3以上的AUROC分别为0.89、0.85和0.78。
  • 基于衰减系数和剪切波色散斜率构建的风险评分识别脂肪性肝炎的AUROC为0.93,显著高于其他参数(P<.05),但与剪切波色散斜率(AUROC 0.89)无显著差异(P=.18)。

核心结论

  • 在疑似NAFLD患者评估中,衰减系数可识别脂肪变,肝硬度可准确检测纤维化,剪切波色散斜率与小叶内炎症显著相关。
  • 基于衰减系数和剪切波色散斜率构建的风险评分可能用于检测脂肪性肝炎。

研究设计与样本

  • 研究纳入102例肝酶升高或疑似NAFLD的患者,于2018年1月至2019年7月在肝活检采集和分析(参考标准)前立即进行衰减成像和二维剪切波弹性成像检查。

主要发现

  • 衰减系数与脂肪变分级相关(P<.01),识别脂肪变分级S1以上、S2以上和S3以上的AUROC分别为0.93、0.88和0.83。
  • 肝硬度与纤维化分期相关(P<.01),小叶内炎症活动是唯一与剪切波色散斜率相关的因素(P<.01)。
  • 剪切波色散斜率识别炎症分级I1以上、I2以上和I3以上的AUROC分别为0.89、0.85和0.78。
  • 基于组织病理学分析,55例患者有脂肪性肝炎;风险评分与NAFLD活动度评分相关(rho=0.73;P<.01)。
  • 风险评分识别脂肪性肝炎的AUROC为0.93,显著高于其他参数(P<.05),但与剪切波色散斜率(AUROC 0.89)无显著差异(P=.18)。

关键数值与推荐

  • 风险评分系统基于衰减系数(0.64<衰减系数≤0.70计1分;0.70<衰减系数≤0.73计2分;衰减系数>0.73计3分)和剪切波色散斜率(10.5 [m/s]/kHz<剪切波色散斜率≤11.7 [m/s]/kHz计2分;剪切波色散斜率>11.7 [m/s]/kHz计3分),采用各评分未加权求和。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: We evaluated the accuracy of a multiparametric approach using attenuation imaging and 2-dimensional shear wave elastography (2D-SWE) for the detection of steatosis and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). METHODS: We studied 102 patients with increased levels of liver enzymes or suspicion of NAFLD, examined by attenuation imaging and 2D-SWE, immediately before biopsy collection and analysis (reference standard), from January 2018 to July 2019. We collected data on the attenuation coefficient (dB/cm/MHz) from attenuation imaging, liver stiffness measurements, and shear wave dispersion slope (SWDS, [m/s]/kHz) from 2D-SWE. Multivariate linear regression analysis was performed to identify factors associated with each parameter. Diagnostic performance was determined from area under the receiver operating curve (AUROC) values. RESULTS: The attenuation coefficient was associated with steatosis grade (P < .01) and identified patients with steatosis grades S1 or higher, S2 or higher, and S3 or higher, with AUROC values of 0.93, 0.88, and 0.83, respectively. Liver stiffness associated with fibrosis stage (P < .01) and lobular inflammatory activity was the only factor associated with SWDS (P < .01). SWDS detected inflammation grades I1 or higher, I2 or higher, and I3 or higher with AUROC values of 0.89, 0.85, and 0.78, respectively. We developed a risk scoring system to detect steatohepatitis based on the attenuation coefficient (score of 1 for 0.64 < attenuation coefficient ≤ 0.70; score of 2 for 0.70 < attenuation coefficient ≤ 0.73; and score of 3 for attenuation coefficient >0.73) and SWDS (score of 2 for 10.5 [m/s]/kHz < SWDS ≤ 11.7 [m/s]/kHz; and score of 3 for SWDS >11.7 [m/s]/kHz), using an unweighted sum of each score. Based on histopathology analysis, 55 patients had steatohepatitis. Risk scores correlated with NAFLD activity score (rho = 0.73; P < .01). Our scoring system identified patients with steatohepatitis with an AUROC of 0.93-this value was significantly higher than that of other parameters (P < .05), except SWDS (AUROC, 0.89; P = .18). CONCLUSIONS: In the evaluation of patients with suspected NAFLD, the attenuation coefficient can identify patients with steatosis and liver stiffness can detect fibrosis accurately. SWDS was associated significantly with lobular inflammation. We developed a risk scoring system based on the attenuation coefficient and SWDS that might be used to detect steatohepatitis.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Lee DH, Cho EJ, Bae JS, et al. Accuracy of Two-Dimensional Shear Wave Elastography and Attenuation Imaging for Evaluation of Patients With Nonalcoholic Steatohepatitis. Clin Gastroenterol Hepatol. 2020. PMID: 32450363. doi:10.1016/j.cgh.2020.05.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。